NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD
1.21
-0.19 (-13.57%)
The current stock price of IVVD is 1.21 USD. In the past month the price increased by 197.59%. In the past year, price decreased by -71.99%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.85 | 354.98B | ||
AMGN | AMGEN INC | 15.03 | 159.99B | ||
GILD | GILEAD SCIENCES INC | 23.87 | 137.10B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1656.31 | 123.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.25 | 76.09B | ||
ARGX | ARGENX SE - ADR | N/A | 39.34B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.37B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.26B | ||
ONC | BEIGENE LTD-ADR | N/A | 26.06B | ||
NTRA | NATERA INC | N/A | 22.20B | ||
BIIB | BIOGEN INC | 8.32 | 19.98B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.01B |
Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is headquartered in Waltham, Massachusetts and currently employs 94 full-time employees. The company went IPO on 2021-08-06. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The firm delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its PEMGARDA is the Company’s first mAb in a planned series of innovative mAb candidates designed to keep pace with SARS-CoV-2 viral evolution. Its VYD2311 is optimized for neutralization potency against recent SARS-CoV-2 lineages such as BA.2.86 and JN.1. The firm also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.
INVIVYD INC
1601 Trapelo Road, Suite 178
Waltham MASSACHUSETTS US
Employees: 95
Company Website: https://invivyd.com/
Investor Relations: https://investors.invivyd.com/
Phone: 17818190080
The current stock price of IVVD is 1.21 USD. The price decreased by -13.57% in the last trading session.
The exchange symbol of INVIVYD INC is IVVD and it is listed on the Nasdaq exchange.
IVVD stock is listed on the Nasdaq exchange.
9 analysts have analysed IVVD and the average price target is 6.01 USD. This implies a price increase of 396.3% is expected in the next year compared to the current price of 1.21. Check the INVIVYD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INVIVYD INC (IVVD) has a market capitalization of 144.74M USD. This makes IVVD a Micro Cap stock.
INVIVYD INC (IVVD) currently has 95 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IVVD does not pay a dividend.
INVIVYD INC (IVVD) will report earnings on 2025-03-26, after the market close.
INVIVYD INC (IVVD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.96).
The outstanding short interest for INVIVYD INC (IVVD) is 6.88% of its float. Check the ownership tab for more information on the IVVD short interest.
ChartMill assigns a technical rating of 8 / 10 to IVVD. When comparing the yearly performance of all stocks, IVVD turns out to be only a medium performer in the overall market: it outperformed 41.95% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to IVVD. The financial health of IVVD is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months IVVD reported a non-GAAP Earnings per Share(EPS) of -1.96. The EPS decreased by -41.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -139.04% | ||
ROE | -270.72% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 80% to IVVD. The Buy consensus is the average rating of analysts ratings from 9 analysts.